924416-43-3 Usage
Description
SC-396658 is an orally active small molecule AdipoR agonist that binds to adiponectin receptors AdipoR1 and AdipoR2 with KD values of 1.8 and 3.1 μM, respectively. It activates AMPK and PPARα pathways, exerting antidiabetic effects and reducing insulin resistance and glucose intolerance.
Uses
Used in Pharmaceutical Industry:
SC-396658 is used as a therapeutic approach for the treatment of obesity-related diseases such as type 2 diabetes. It activates AMPK and PPARα pathways, ameliorating diabetes and prolonging the lifespan of genetically obese db/db mice on a high-fat diet.
Biochem/physiol Actions
AdipoRon is an adiponectin agonist that binds to and activates adiponectin receptors AdipoR1 and AdipoR2, activating AMPK and PPAR-α pathways, and ameliorating insulin resistance and glucose intolerance in mice fed a high-fat diet in a manner similar to adiponectin itself. AdipoRon did not affect body weight, but did increase the expression of genes involved in fatty-acid oxidation, decreased tissue triglyceride content, and prolonged the shortened lifespan of db/db mice.
References
1) Okada-Iwabu?et al. (2013),?A small-molecule AdipoR agonist for type 2 diabetes and short life obesity; Nature 503?493
2) Fairaq?et al.?(2017),?AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia; Pharmacol. Res.?119?289
Check Digit Verification of cas no
The CAS Registry Mumber 924416-43-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,4,4,1 and 6 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 924416-43:
(8*9)+(7*2)+(6*4)+(5*4)+(4*1)+(3*6)+(2*4)+(1*3)=163
163 % 10 = 3
So 924416-43-3 is a valid CAS Registry Number.
924416-43-3Relevant articles and documents
ACTIVATOR OF ADIPONECTIN RECEPTOR
-
, (2016/08/17)
An AdipoR activator for activating both AdipoR1 and AdipoR2 is provided. A compound represented by the following formula (1), wherein A is a substituted or unsubstituted aryl group or the like, Y1 is (CHR2)a— or the like, X is CH or N, R1 is a C1-7 alkyl group, m is an integer of 0-4, Y2 is *—O—CH2—CONH—, *—CONH—(CH2)b—CO— or the like, Z is a cyclic group, B may be a substituent of the cyclic group represented by Z, and n is an integer of 0-3.